<DOC>
	<DOCNO>NCT01534065</DOCNO>
	<brief_summary>The purpose multi-center post marketing surveillance study monitor safety performance Barricaid® ARD use surgically reconstruct anulus L1 - S1 spinal disc .</brief_summary>
	<brief_title>Barricaid EU Post Market Study Primary Lumbar Disc Herniation</brief_title>
	<detailed_description />
	<mesh_term>Intervertebral Disc Displacement</mesh_term>
	<mesh_term>Hernia</mesh_term>
	<criteria>1 . Age 18 75 year old ( male female ) . 2 . Patients posterior posterolateral disc herniation one two level L1 S1 radiographic confirmation neural compression use CT and/or MRI . 3 . At least six ( 6 ) week fail , conservative treatment prior surgery , include physical therapy , use antiinflammatory medication maximum specified dosage and/or administration epidural/facet injection . ; 4 . Minimum posterior disc height 3mm index level ( ) . 5 . Lower back pain and/or sciatica without spinal claudication . 6 . Oswestry Questionnaire score least 40/100 baseline . 7 . VAS leg pain least 40/100 baseline . 1 . Spondylolisthesis Grade II high 2 . Subject require uni bilateral facetectomy treat leg/back pain 3 . Subject back nonradicular leg pain unknown etiology . 4 . Prior fusion ( without instrumentation ) , motion preservation , facetectomy IDET surgery index lumbar vertebral level 5 . Subject 's require spine DEXA ( i.e. , patient SCORE ≥ 6 ) T Score less 2.0 index level . 6 . Subject clinically compromised vertebral body index level ( ) due traumatic , neoplastic , metabolic , infectious pathology . 7 . Subject sustain pathologic fracture vertebra multiple fracture vertebra hip . 8 . Subject scoliosis great ten ( 10 ) degree ( angular rotational ) . 9 . Any metabolic disease bone disease stabilize least three month ( e.g. , Paget 's disease , osteomalacia , osteogenesis imperfecta , thyroid and/or parathyroid gland disorder , etc. ) . 10 . Subject active infection either systemic local . 11 . Subject cauda equine syndrome neurogenic bowel/bladder dysfunction . 12 . Subject severe arterial insufficiency leg ( Screening physical examination= patient diminution absence dorsalis pedis posterior tibialis pulse . If diminish absent palpation , arterial ultrasound require vascular plethysmography . If absolute arterial pressure 50mm Hg calf ankle level , patient exclude ) peripheral vascular disease ) . 13 . Subject significant peripheral neuropathy , patient define patient Type I Type II diabetes similar systemic metabolic condition cause decrease sensation stockinglike nonradicular nondermatomal distribution low extremity . 14 . Subject insulindependent diabetes mellitus . 15 . Subject morbidly obese ( define body mass index &gt; 40 , weigh 100 lbs ideal body weight ) . 16 . Subject diagnose active hepatitis , AIDS , HIV . 17 . Subject diagnosed rheumatoid arthritis autoimmune disease . 18 . Subject know allergy titanium , polyethylene polyester material . 19 . Subject pregnant interested become pregnant next three ( 3 ) year . 20 . Subject active tuberculosis tuberculosis past three ( 3 ) year . 21 . Subject history active malignancy : A patient history invasive malignancy ( except nonmelanoma skin cancer ) , unless he/she treat curative intent sign symptom malignancy least two ( 2 ) year . 22 . Subject immunologically suppress , receive steroid &gt; 1 month past year . 23 . Currently take anticoagulant , aspirin , unless patient take anticoagulant surgery 24 . Subject current chemical/alcohol dependency significant psychosocial disturbance . 25 . Subject life expectancy less three ( 3 ) year .</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>November 2016</verification_date>
	<keyword>Hernia</keyword>
	<keyword>Intervertebral Disk Displacement</keyword>
	<keyword>Pathological Conditions , Anatomical</keyword>
	<keyword>Spinal Diseases</keyword>
	<keyword>Bone Diseases</keyword>
	<keyword>Musculoskeletal Diseases</keyword>
</DOC>